Choose Category
COVID-19
NIDA: Potential Implications for Individuals with Substance Use Disorders
March 12, 2020Nora Volkow, M.D., Director of the National Institute on Drug Abuse (NIDA), highlights the added risks that populations with substance use disorder face during the COVID-19 pandemic.
Program Advisory Meeting
Improving Clinical Practice for Pain
August 23, 2019Expert advisory meeting convened by FORE to discuss pain management and consider barriers to implementing or changing pain management practices.
Program Advisory Meeting
Delivery System and Payment Models
July 10, 2019Expert advisory meeting convened by FORE to consider the healthcare delivery system and payment model changes that are needed to facilitate access to treatment.
Program Advisory Meeting
Medical Education and Training
June 26, 2019Expert advisory meeting convened by FORE to explore opportunities in medical education and training related to preventing, screening, and treating opioid use disorder.
Program Advisory Meeting
Access to Treatment
May 14, 2019Expert advisory meeting convened by FORE to highlight barriers and address challenges that patients with opioid use disorder face in accessing appropriate treatment.